最新报道:According to Bijie.com, Hong Kong-listed Huajian Medical (01931.HK) saw another 9% intraday increase, bringing its cumulative gain over the past four weeks to over 200%. As of press time, the stock was up 7.3% at HK$6.17, with a turnover of HK$23.3243 million. Bijie.com previously reported that Huajian Medical announced at the end of July that it had entered into a strategic cooperation framework agreement with BGI CoWin to jointly establish the Huajian-BGI CoWin Innovative Drug Intellectual Property Tokenization Fund (IVD-BGI CoWin).